Almirall Partners with CrystalO to Discover Novel Dermatology Drugs
Barcelona, Spain, August 9, 2026 Almirall announced a collaboration and licensing agreement with CrystalO, a China-based biotechnology company, to...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Barcelona, Spain, August 9, 2026 Almirall announced a collaboration and licensing agreement with CrystalO, a China-based biotechnology company, to...
Boston, MA, August 9, 2026 Asimov announced the successful completion of a cell line development campaign in collaboration with...
